✦ LIBER ✦

Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy

✍ Scribed by Salah-Eldin, Manal A.; Ebrahim, Mohamed A.; El-Sadda, Wael

Book ID: 125344224
Publisher: Springer
Year: 2014
Tongue: English
Weight: 580 KB
Volume: 93
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-014-2138-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant statin use does not impair t

Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP

✍ Panagiotis Samaras; Helen Heider; Sarah R. Haile; Ulf Petrausch; Niklaus G. Scha 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 154 KB

Serum neuron-specific enolase is correla

Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy

✍ Liang Wang, Panpan Liu, Xiaoqin Chen, Qirong Geng, Yue Lu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 248 KB

CHOP Chemotherapy plus Rituximab Compare

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

✍ Coiffier, Bertrand; Lepage, Eric; Brière, Josette; Herbrecht, Raoul; Tilly, Herv 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 116 KB

CHOP Chemotherapy plus Rituximab Compare

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

✍ Coiffier, Bertrand; Lepage, Eric; Brière, Josette; Herbrecht, Raoul; Tilly, Herv 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 116 KB

## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct

Vitamin D Deficiency Impairs Rituximab-M

Vitamin D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With but Not Without Rituximab

✍ Bittenbring, J. T.; Neumann, F.; Altmann, B.; Achenbach, M.; Reichrath, J.; Ziep 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 442 KB

Improved survival with rituximab-based c

Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma

✍ Olszewski, Adam J.; Winer, Eric S.; Castillo, Jorge J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 750 KB